Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients

Completed · Not applicable

Conditions studied: Diabetes, Hypertension, Dyslipidemia, Coronary Arteriosclerosis

In brief

The purpose of this research is to study whether a multidisciplinary education in Diabetes and intervention for cardiac risk reduction in a group setting to modify patient behavior and adjust medications can achieve diabetes guideline goals for glycemia, blood pressure and lipid control.

Key facts

Study ID

NCT00357955

Run by

Providence VA Medical Center

People needed

118

Starts

2004-08-01

Expected to finish

2008-05-01

Last updated by the study team

2024-11-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All diabetic veterans with a Hb-A1c between 7.0- 9.0 % within the last 6 months will be eligible for the study

You may not qualify if…

• Patients without an Hb-A1c checked within the last 6 months.
• Patients who are unable to attend the group sessions, either because of lack of transportation, psychiatric instability (suicidal, psychotic), or organic brain injury that preclude them from diabetes self-care.

Where it is running

• Providence VAMC — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.